Lipocine
LPCN
LPCN
29 hedge funds and large institutions have $10.1M invested in Lipocine in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
12% less funds holding
Funds holding: 33 → 29 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
29
Holding in Top 10
–
Calls
$902K
Puts
$210K
Top Buyers
| 1 | +$2.61M | |
| 2 | +$1.25M | |
| 3 | +$605K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$357K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$142K |
Top Sellers
| 1 | -$398K | |
| 2 | -$252K | |
| 3 | -$122K | |
| 4 |
Millennium Management
New York
|
-$79K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$58K |